While no significant changes were observed in free testosterone or SHBG levels, treatment with GLP-1 RAs was associated with a significant rise in bioavailable testosterone and a notable reduction in HbA1c, indicating potential dual metabolic and endocrine benefits
NICE recommends lifestyle and dietary support alongside GLP-1 treatment (NICE NG28), with patients benefiting from comprehensive dietary counselling to optimise treatment outcomes and minimise side effects
Baseline demographics and clinical characteristics A total of 7,215 randomized participants were included in the meta-analysis (pooled tirzepatide group treated with a mean assigned dose of 9.9 mg per week of tirzepatide, n = 4,887 (1 mg, n = 52
Item formCapsule Colour1 Bottle
For people undergoing the menopausal transition and struggling with weight loss, GLP-1s could offer a safe, clinically-proven way to improve overall health
Q3: What quality assurance measures ensure batch-to-batch consistency